These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18516972)

  • 1. [Use of botulinum toxin for pain therapy].
    Nodera H
    Brain Nerve; 2008 May; 60(5):503-8. PubMed ID: 18516972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
    Luvisetto S; Gazerani P; Cianchetti C; Pavone F
    Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
    Chiu B; Tai HC; Chung SD; Birder LA
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects.
    Borodic GE; Acquadro M; Johnson EA
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1531-44. PubMed ID: 11772268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
    Bagues A; Hu J; Alshanqiti I; Chung MK
    Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
    Dolly JO; Wang J; Zurawski TH; Meng J
    FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of the use of botulinum toxin in orofacial pain disorders.
    Clark GT; Stiles A; Lockerman LZ; Gross SG
    Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Toxin for the Treatment of Neuropathic Pain.
    Park J; Park HJ
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of botulinum toxin in migraine: mechanisms of action.
    Ramachandran R; Yaksh TL
    Br J Pharmacol; 2014 Sep; 171(18):4177-92. PubMed ID: 24819339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
    Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
    J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin to treat pelvic pain.
    Zhang Y; Smith CP
    Toxicon; 2018 Jun; 147():129-133. PubMed ID: 28847706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.
    Eubanks LM; Dickerson TJ
    Future Microbiol; 2007 Dec; 2(6):677-87. PubMed ID: 18041908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
    Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
    J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
    Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
    FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
    Halb L; Amann BJ; Bornemann-Cimenti H
    Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Jhang JF; Jiang YH; Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.